Cargando…

Cost-effective BRCA Testing in Advanced Ovarian Cancer

Detalles Bibliográficos
Autor principal:	Kim, Myungshin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Laboratory Medicine 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467842/ https://www.ncbi.nlm.nih.gov/pubmed/36045051 http://dx.doi.org/10.3343/alm.2023.43.1.3

Ejemplares similares

Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer
por: Jang, Jaehyeok, et al.
Publicado: (2023)

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer
por: Eccleston, Anthony, et al.
Publicado: (2017)

Peripheral blood BRCA1 methylation profiling to predict familial ovarian cancer
por: Jung, Yuyeon, et al.
Publicado: (2021)

The role of BRCA1-IRIS in ovarian cancer formation, drug resistance and progression
por: ElShamy, Wael M.
Publicado: (2016)

UK BRCA mutation testing in patients with ovarian cancer
por: George, Angela
Publicado: (2015)

New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study
por: Plaskocinska, Inga, et al.
Publicado: (2016)

Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?
por: Liu, Guo-Yan, et al.
Publicado: (2012)

Comments on: Peripheral blood BRCA1 methylation profiling to predict familial ovarian cancer
por: Kwon, Janice S.
Publicado: (2021)

From Genetic Testing to Treatment and Prevention of BRCA-Related Breast Cancer
por: Ki, Chang-Seok
Publicado: (2020)

BRCA mutation in ovarian cancer: testing, implications and treatment considerations
por: Neff, Robert T., et al.
Publicado: (2017)

BRCA germline mutation test for all woman with ovarian cancer?
por: Paradiso, A. V., et al.
Publicado: (2019)

Comparison of Targeted Next-Generation and Sanger Sequencing for the BRCA1 and BRCA2 Mutation Screening
por: Park, Joonhong, et al.
Publicado: (2016)

Recent advances in the biomarkers for epithelial ovarian cancer
por: Kim, Yun Hwan, et al.
Publicado: (2011)

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer
por: Colombo, Ilaria, et al.
Publicado: (2018)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
por: Kim, Se Ik, et al.
Publicado: (2019)

Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects
por: Peixoto, Ana, et al.
Publicado: (2020)

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer
por: Bekos, Christine, et al.
Publicado: (2021)

Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
por: Cham, Stephanie, et al.
Publicado: (2022)

Practice guidelines for BRCA1/2 tumour testing in ovarian cancer
por: Grafodatskaya, Daria, et al.
Publicado: (2022)

Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer
por: Oda, Katsutoshi, et al.
Publicado: (2022)

Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
por: Lee, Chee Khoon, et al.
Publicado: (2019)

Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?
por: Nguyen-Dumont, Tu, et al.
Publicado: (2020)

Ovarian Cancer: Advances in Pathophysiology and Therapies
por: Tossetta, Giovanni, et al.
Publicado: (2023)

Ovarian Cancer: Latest Advances and Prospects
por: Dion, Ludivine, et al.
Publicado: (2021)

Niraparib and Advanced Ovarian Cancer: A Beacon in the Non-BRCA Mutated Setting
por: Maiorano, Mauro Francesco Pio, et al.
Publicado: (2023)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
por: Manchana, Tarinee, et al.
Publicado: (2020)

Characterization of BRCA Deficiency in Ovarian Cancer
por: Barbero, Giovanna, et al.
Publicado: (2023)

The BRCA Gene in Epithelial Ovarian Cancer
por: Sánchez-Lorenzo, Luisa, et al.
Publicado: (2022)

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study
por: Girardi, Fabio, et al.
Publicado: (2018)

Editorial: BRCA1 and BRCA2 gene mutations screening in sporadic breast cancer patients in Kazakhstan
por: Jankowitz, Rachel C., et al.
Publicado: (2013)

A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention
por: Hanley, Gillian E., et al.
Publicado: (2018)

Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with BRCA1 or BRCA2 Mutation
por: Jeong, Go Woon, et al.
Publicado: (2021)

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
por: Arakelyan, Arsen, et al.
Publicado: (2021)

Looking for BRCA1 and BRCA2 mutations in Asian women with breast cancer
por: Narod, Steven A.
Publicado: (2023)

NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer
por: Marchetti, Claudia, et al.
Publicado: (2021)

Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers
por: Omole, Emmanuel B., et al.
Publicado: (2022)

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
por: Ashour, Mohamed, et al.
Publicado: (2019)

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2021)

BRCA mutations in the manifestation and treatment of ovarian cancer
por: Pan, Zimin, et al.
Publicado: (2017)

Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
por: Metcalfe, K A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_38saum0uumkno9kdmscvsp7ncc